20936 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
METHODS FOR PREVENTING AND TREATING BRAIN INFLAMMATION
#2PHOTOSOLIDIFICATION METHODS AND COMPOSITIONS FOR GENERATING BIOCOMPATIBLE ARCHITECTURES
#3Silk Fibroin/Tea Polyphenol Hydrogel and Preparation Method and Application Thereof
#4Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#5Transgenic Corn With Antifungal Peptide AGM182 (DN:0113.18)
#6TREATMENT OF RETINAL GANGLION CELL LOSS
#7Oyster peptide kidney-nourishing formula composition and preparation method
#8SUBLINGUAL TABLET AND APPLICATION THEREOF IN DESENSITIZATION THERAPY DRUG
#9SILK PEPTIDES TOPICAL FORMULATIONS AND METHODS OF THEIR USE
#10Apoaequorin-Containing Compositions and Method of Using Same to Treat Neuronal Inflammation
#11ANNELID HEMOGLOBIN FOR USE IN THE TREATMENT OF FUCHS' DISEASE
#12COMPOSITIONS AND METHODS FOR THE MODULATION OF PIEZO1 AND TRPV4
#13METHODS OF REDUCING THE SIGNS OR SYMPTOMS OF DERMAL DISORDERS WITH TOPICALLY APPLIED SILK FIBROIN
#14TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS
#15ANTICOAGULANT PROTEINS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH THE ACTIVATION OF NEUTROPHILS
#16Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking
#17USE OF GsMTx4 AND GsMTx4 CONJUGATES TO IMPROVE RECOVERY FROM JOINT INJURY
#18PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#19COMPOSITIONS AND METHODS FOR REDUCING BIOFILM FORMATION
#20Coversin for use in the treatment of rheumatic diseases
#21METHOD FOR SUSTAINED DRUG DELIVERY FOR WOUND HEALING USING SILK HYDROGEL AND PRODUCT THEREOF
#22METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#23METHODS FOR PREVENTING AND TREATING BRAIN INFLAMMATION
#24VERSATILE IMMUNOGENIC MODULES AND NANOPARTICLES FOR TICK VACCINES
#25MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
#26ANTIVIRAL COMPOSITION COMPRISING OCTOMININ
#27MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
#28SILK STIMULATED COLLAGEN AND CLAUDIN-1 EXPRESSION, AND SILK STIMULATED ANTI-INFLAMMATORY EFFECTS
#29SILK FIBROIN-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#30Transgenic Corn With Antifungal Peptide AGM182 (DN:0113.18)
#31COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
#32TREATMENT SYSTEM FOR SYNERGISTICALLY INHIBITING A SPROUT ANGIOGENESIS
#33COMPOSITION AND METHOD OF TREATING BRAIN CANCER
#34COMPOSITIONS AND METHODS FOR MODULATING GLYCEMIC RESPONSE
#35STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#36ANTI-ANGIOGENIC TREATMENT USING ECHISTATIN WITH A BLOCKING PEPTIDE
#37MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#38Dental enamel compositions with anti-inflammatory agents
#39DRUG WITH PROLONGED ANALGESIC ACTION
#40OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#41ANTICOAGULANT PROTEINS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH THE ACTIVATION OF NEUTROPHILS
#42METHODS AND COMPOSITIONS FOR TREATMENT OF AUTOIMMUNE CONDITIONS
#43INJECTABLE SILK FIBROIN FOAMS AND USES THEREOF
#44Inhibitors of the tissue factor-protease activated receptor 2 (TF-PAR2) signaling pathway for use in the treatment or prevention of heart failure (HF) and associated or resulting diseases
#45Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
#46MEMBRANE-ACTIVE PEPTIDES AND METHODS FOR REVERSIBLE BLOOD- BRAIN BARRIER OPENING
#47SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#48TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS
#49Antimicrobial peptide Spampcinfrom and applications thereof
#50NANOPARTICLE IN WHICH ANTIBACTERIAL PEPTIDE IS ENCAPSULATED WITH CHITOSAN AND USE THEREOF
#51Methods and compositions with purified cocoon silk peptide fiber and refined seed oil providing anti-inflammatory effects and neuroprotection for disease states
#52OCTOPUS-DERIVED PEPTIDE OCTOPROMYCIN HAVING ANTIBACTERIAL AND ANTI-BIOFILM ACTIVITY AGAINST ACINETOBACTER BAUMANNII
#53Apoaequorin and Curcumin Containing Compositions and Methods
#54SILK-BASED PRODUCT FORMULATIONS AND METHODS OF USE
#55Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#56Compositions and methods for blocking ultraviolet radiation
#57Dental enamel compositions with anti-inflammatory agents
#58ENTERIC-COATED GRANULAR COMPOSITION COMPRISING INGREDIENTS DERIVED FROM BEE VENOM AND LACTIC ACID BACTERIA
#59LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#60COMPOSITION AND METHODS FOR PREVENTING RADIATION INJURY AND PROMOTING TISSUE REGENERATION
#61HYDROPHOBIC SILK FIBROIN COMPOSITIONS AND METHODS OF MAKING THE SAME
#62THERAPEUTIC MOLECULES FOR COMBATING SEPSIS
#63Apoaequorin and Curcumin Containing Compositions and Methods
#64SYSTEMS, DEVICES, AND METHODS FOR TREATING A PULMONARY DISORDER WITH AN AGENT
#65METHOD FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERS
#66METHODS OF TREATING VASCULAR LESIONS AND MALFORMATIONS
#67CHIMERIC CHLOROTOXIN RECEPTORS
#68PHARMACEUTICAL COMPOSITION COMPRISING SMALL OCTOPUS-DERIVED PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASE
#69COMPOSITION MODULATING BOTULINUM NEUROTOXIN EFFECT
#70Muscle Tissue-Regenerating Agent
#71RECOMBINANT FASCIOLA HEPATICA FATTY ACID BINDING PROTEIN (FH15): AN ANTI-INFLAMMATORY BIOTHERAPEUTIC
#72Method of Treatment
#73Methods of making stable silk fibroin formulations
#74Methods and compositions with purified cocoon silk peptide fiber and refined seed oil providing anti-inflammatory effects and neuroprotection for disease states
#75DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH
#76PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS
#77TARGETING CAPN9/CAPNS2 ACTIVITY AS A THERAPEUTIC STRATEGY FOR THE TREATMENT OF MYOFIBROBLAST DIFFERENTIATION AND ASSOCIATED PATHOLOGIES
#78PEPTIDE SCYREPROCIN OF SCYLLA PARAMAMOSAIN AND METHOD THEREOF
#79METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCK
#80METHODS AND ARTICLES FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA
#81A Composition And Method For Improving The Profile Of Blood
#82PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR APPLYING GANODERMA MICROSPORUM IMMUNOMODULATORY PROTEIN AND KEYHOLE LIMPET HEMOCYANIN IN CARCINOMA TREATMENT
#83TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#84Method of Treating Peripheral Nerve Disorders
#85COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING CEREBROVASCULAR DISEASE COMPRISING MELITTIN OR MAGNETIC IRON OXIDE NANOPARTICLE LOADED WITH MELITTIN AS EFFECTIVE COMPONENT
#86Anti-angiogenic treatment using VLO4 with a blocking peptide
#87Method of Treatment
#88AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#89Treatment of ischemia
#90Lipoprotein targeting protease inhibitors and uses
#91Dental enamel compositions with anti-inflammatory agents
#92COMPOSITION COMPRISING SERICIN FOR TREATING, PREVENTING, OR ALLEVIATING FATTY LIVER, AND METHOD OF PREPARING SAME
#93PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF
#94Coversin for Use in the Treatment of Rheumatic Diseases
#95COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH
#96Antiepileptic toxin Martentoxin and use thereof
#97METHODS AND COMPOSITIONS FOR TREATING CANCER USING CHRNA6 INHIBITORS
#98Bee venom-purifying method comprising viral clearance process and composition for preventing or treating inflammatory disease by using same
#99COMPOSITION FOR IMPROVING MEMORY, OR COMPOSITION FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE, COMPRISING ANGELICA ROOT EXTRACT AND SILKWORM PRODUCT HAVING SILK PROTEIN
#100FORMULATION FOR TOPICAL TREATMENT OF ACUTE WOUNDS
#101METHODS AND COMPOSITIONS FOR TREATMENT OF CORONAVIRUS INFECTION AND ASSOCIATED COAGULOPATHY
#102PHARMACEUTICAL COMPOSITION FOR TREATING WOUNDS
#103Preparation of fibroin and therapeutic products made thereof
#104TREATMENTS AGAINST MOSQUITO-BORNE VIRUSES BASED ON MOSQUITO SALIVARY GLAND PROTEINS
#105PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH CTM TARGETING
#106DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS
#107Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
#108Method for visually enhancing the experience of an audience during a performance
#109Ornithodoros Moubata Complement Inhibitor for Use in the treatment of Complement-Mediated Diseases in Patients with C5 Polymorphism
#110Composition for diagnosing allergies to mites, method of diagnosing allergies to mites, and composition for preventing or treating allergies to mites
#111METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#112Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide
#113Silk-based product formulations and methods of use
#114MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES
#115USE OF HEMOLYMPH OR HEMOLYMPH COMPONENTS FOR THE TREATMENT AND PREVENTION OF INFLAMMATION AND DRY SKIN
#116Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof
#117Combination therapies for inhibiting sprout angiogenesis in the treatment of cancers
#118Apoaequorin and vitamin d-containing compositions and methods of using same
#119Compositions and methods for blocking ultraviolet radiation
#120PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR APPLYING GANODERMA MICROSPORUM IMMUNOMODULATORY PROTEIN AND KEYHOLE LIMPET HEMOCYANIN IN CARCINOMA TREATMENT
#121Topical formulations comprising montelukast and combinations with mussel adhesive proteins
#122Formulations and methods of use for alpha connexin c-terminal (ACT) peptides
#123SILK FIBROIN-CONTAINING COMPOSITION AND METHODS OF USE THEREOF
#124MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#125Annelid haemoglobin lyophilisation process
#126Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
#127USE OF HEMOGLOBIN FROM ANNELIDS AS BACTERICIDE, IN PARTICULAR FOR PREVENTING AND/OR TREATING A PERIODONTAL DISEASE
#128METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASES
#129Topical silk compositions and methods of using
#130Dental enamel compositions with anti-inflammatory agents
#131TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#132Compositions for inhibiting sprout angiogenesis
#133METHODS AND COMPOSITION FOR THE TREATMENT OF ALLERGIC ASTHMA
#134Radiation-triggered liposomes
#135ANTIMICROBIAL PEPTIDES
#136Methods of treating fungal infections
#137Anti-angiogenic treatment with a combination of antagonists
#138ANTICOAGULANT PROTEINS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH THE ACTIVATION OF NEUTROPHILS
#139MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
#140Treatment of ischemia
#141DELIVERY SYSTEM FOR FUNCTIONAL NUCLEASES
#142Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
#143Stapled intracellular-targeting antimicrobial peptides to treat infection
#144Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#145Proteinaceous molecules and methods of use
#146Porous implantable devices
#147Method of Treating Myasthenia Gravis
#148Compositions and methods for inhibiting biofilm-forming bacteria
#149MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES
#150AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#151Mussel adhesive protein product and applications thereof in suppression of skin inflammations
#152Chlorotoxin agents and uses thereof
#153Composition including melittin for removing M2-type tumor-associated macrophage
#154Method for synthesis of protein amphiphiles
#155Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#156Use of interleukin-4-inducing principle of eggs for treating pain, interstitial cystitis and/or overactive bladder
#157EV576 For Use in the Treatment of Viral Infections of the Respiratory Tract
#158Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same
#159Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA)
#160Methods of treating fungal infections
#161Mussel adhesive protein product and use thereof for treating mucosal inflammation
#162Compositions and Methods for Topical and Diagnostic and Therapeutic Transport
#163Inhibitors of LTβR-NFκB signaling pathways for treating inflammation and cancer
#164Transgenic corn with antifungal peptide AGM182 USDA (DN:0113.18)
#165LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#166Inhibiting sprout angiogenesis
#167Neuroprotective agents derived from spider venom peptides
#168Chimeric chlorotoxin receptors
#169Protoxin-II variants and methods of use
#170Modified polynucleotides for the production of secreted proteins
#171TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#172APOAEQUORIN AND VITAMIN D-CONTAINING COMPOSITIONS AND METHODS OF USING SAME
#173NOVEL MEANS TO DECREASE THE NEGATIVE EFFECTS OF SMOKING
#174Compositions and methods for blocking ultraviolet radiation
#175Modified polynucleotides for the production of secreted proteins
#176ANTIMICROBIAL PEPTIDES
#177Antimicrobial peptides
#178Methods of treating breast cancer
#179Treatment of ischemia
#180OPTOGENETIC VISUAL RESTORATION USING CHRIMSON
#181Method for administering omega-conopeptide
#182Immunomodulator for hypersensitivity reaction to house dust mite-derived allergen
#183Method for visually enhancing the experience of an audience during a performance
#184PRODUCING METHOD OF ANTIMICROBIAL PEPTIDE WITH ENHANCED ADHESION AND USES THEREOF
#185USE OF EARTHWORM PROTEIN FOR PREPARING PHARMACEUTICAL COMPOSITION FOR PROTECTION OF BRAIN NEURONS
#186Combination of antimicrobial peptides and antibiotic drugs for treating diseases
#187Use of La1-like peptide isolated from maurus palmatus venom as an activator of sperm motility in mammals
#188Anti-infective properties of antifreeze protein
#189Method to enhance wound healing using silk-derived protein
#190Method of Treating Peripheral Nerve Disorders
#191Compositions and their use for controlling the nervous system in vivo
#192LIPOCALIN FUSION PARTNERS
#193COMPOSITION FOR DIAGNOSING ALLERGIES TO MITES, METHOD OF DIAGNOSING ALLERGIES TO MITES, AND COMPOSITION FOR PREVENTING OR TREATING ALLERGIES TO MITES
#194EVASINS FOR USE IN THERAPY AND DIAGNOSTICS
#195TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#196ANTI-INFLAMMATORY COMPOSITION COMPRISING CLAVASPIRIN PEPTIDE ANALOGUE AS EFFECTIVE INGREDIENT
#197AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#198Anti-wrinkle and anti-aging cosmetic composition comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component
#199vaccine
#200Ferritin nanoparticle compositions and methods to modulate cell activity
#201Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
#202Formulation for targeting cancer in humans and canines using chlorotoxin
#203Treatment of learning disabilities and other neurological disorders with SK channel inhibitor(s)
#204Formulation for targeting cancer in humans and canines using venom
#205Treatment of ischemia
#206GENETIC METHOD TO KILL CANCER CELLS BY SUFFOCATION
#207TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION
#208Methods relating to the diagnosis and treatment of preeclampsia comprising administration of ADAMTS13 polypeptides
#209Methods of treating fungal infections
#210Mussel adhesive protein product and use thereof for treating mucosal inflammation
#211Delivery of negatively charged proteins using cationic lipids
#212Mussel adhesive protein product and applications thereof in suppression of skin inflammations
#213Functionalized protein-based materials and their uses
#214Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
#215APOAEQUORIN-CONTAINING COMPOSITIONS AND METHODS OF USING SAME TO TREAT NEURONAL INFLAMMATION
#216Neuroprotective agents derived from spider venom peptides
#217ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE
#218MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF NUCLEAR PROTEINS
#219DENDRITIC CELL INHIBITORY PROTEINS FROM TICKS
#220MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#221INTRACELLULAR DELIVERY SYSTEM AND METHODS
#222Alpha connexin c-terminal (ACT) peptides and methods of use thereof
#223Immunogenic compositions and vaccines for preventing or treating filarial disease
#224TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#225Light-absorbing compositions and methods of use
#226Modified polynucleotides for the production of oncology-related proteins and peptides
#227Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#228Treatment of ischemia
#229NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF
#230LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#231Method for administering omega-conopeptide
#232One component fibrin glue comprising zymogens
#233ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS
#234STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#235Substituted benzo[f]imidazo[1,2-a]quinoxalines
#236Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with C5 polymorphism
#237ANTI-INFLAMMATORY PROTEINS AND PEPTIDES AND METHODS OF PREPARATION AND USE THEREOF
#238Therapeutic conjugates with sulfated dendrimers for intracellular targeting
#239ANTI-INFLAMMATORY PROTEINS AND METHODS OF PREPARATION AND USE THEREOF
#240Cosmetic composition comprising a muconopeptide
#241TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#242Compositions and methods for promoting wound healing and tissue regeneration
#243Dressing for promotion of wound healing
#244Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channels
#245Modified antibiotic peptides having variable systemic release
#246ANTINEMATODAL METHODS AND COMPOSITIONS
#247USE OF GSMTX4 TO REDUCE ISCHEMIA REPERFUSION INJURY
#248EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT
#249Peptide-Based In Vivo siRNA Delivery System
#250METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES
#251Treatment of proliferative disorders with a chemiluminescent agent
#252Injectable silk fibroin foams and uses thereof
#253Short Bio-Active Peptides for Promoting Wound Healing
#254Modified polynucleotides for the production of secreted proteins
#255Antimicrobial peptides
#256Compositions and Formulations for Increasing Renal Function and Treatment and Prevention of Renal Diseases, and Methods of Production and Use Thereof
#257Compositions and methods to modulate cell activity
#258USE OF RNA INTERFERENCE, FARNESOIC ACID AND RECOMBINANT PROTEIN APPROACH TO INDUCE GONAD MATURATION IN CRUSTACEAN SPECIES
#259Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#260SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF
#261Anti-viral cnidarins
#262PROCESS FOR PRODUCTION OF BIVALIRUDIN
#263Anti-infective properties of antifreeze protein
#264Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#265Protoxin-II variants and methods of use
#266DENDRITIC CELL MODULATORY MOLECULE
#267Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces
#268Method of treating viral diseases and proliferative disorders
#269Treatment of ischemia
#270INCLUSION BODIES FOR TRANSDERMAL DELIVERY OF THERAPEUTIC AND COSMETIC AGENTS
#271ANTI-INFLAMMATORY PROTEINS AND METHODS OF USE
#272Delivery system for functional nucleases
#273OINTMENT CONTAINING A HYDROLYZED FIBROIN AND MANUFACTURING METHOD OF SAME
#274Silk-elastin like protein polymers for embolization and chemoembolization to treat cancer
#275METHOD OF TREATING PERIPHERAL NERVE DISORDERS
#276METHOD OF TREATING MYASTHENIA GRAVIS
#277Antimicrobial Peptide Variants and Polynucleotides Encoding Same
#278Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereof
#279METHOD FOR EXTRACTING ORGANIC SOLIDS AND OIL FROM MARINE ORGANISMS ENRICHED WITH ASTAXANTHIN
#280Compositions comprising fibrous polypeptides and polysaccharides
#281METHOD OF TREATING VIRAL DISEASES
#282METHODS OF PREPARING AND USING SERICIN HYDROGEL
#283Methods of regulating skin health and appearance with a combination of flavonoid and vitamin B
#284Method of treating cancer
#285Conjugate comprising P21 protein for the treatment of cancer
#286USE OF TAENIA SOLIUM RECOMBINANT CALRETICULIN FOR INDUCING INTERLEUKIN-10 EXPRESSION
#287Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#288SHK-based pharmaceutical compositions and methods of manufacturing and using the same
#289Stable amorphous calcium carbonate comprising synthetic phosphorylated peptides
#290Potent and selective inhibitors of Nav1.7
#291METHODS, SYSTEMS AND DEVICES FOR OPTICAL STIMULATION OF TARGET CELLS USING AN OPTICAL TRANSMISSION ELEMENT
#292Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
#293METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS
#294Treatment of metastatic tumors
#295Polypeptide hydrogel and method for producing same
#296Method for administering ω-conopeptide
#297TMEM120A ion channel modulator
#298Modified polynucleotides for the production of secreted proteins
#299T cell balance gene expression, compositions of matters and methods of use thereof
#300INTRACELLULAR DELIVERY SYSTEM AND METHODS